Role of interleukin-10 in breast cancer. (Q37953317)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057973%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Role of interleukin-10 in breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057973%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057973%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Hamidullah

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057973%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Bendangla Changkija

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057973%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

language of work or name

English

0 references

publication date

5 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057973%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

16 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057973%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

133

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057973%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057973%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

11-21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057973%20AND%20SRC:MED&resulttype=core&format=json

Global cancer statistics, 2002

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Use of statistics to assess the global burden of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Cytokines in cancer immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Cytokines in the management of high risk or advanced breast cancer: an update and expectation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Breast cancer risk associated with polymorphisms of IL-1RN and IL-4 gene in Indian women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Identification and functional characterization of a second chain of the interleukin-10 receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Biological properties of interleukin 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Interleukin-10 and the interleukin-10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Interleukin-10 and related cytokines and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Regulation and functions of the IL-10 family of cytokines in inflammation and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Interleukin-10 therapy--review of a new approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Biology of interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Cutting edge: immune cells as sources and targets of the IL-10 family members?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

IL-10: the master regulator of immunity to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

T(H)1 cells control themselves by producing interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Functional regions of the mouse interleukin-10 receptor cytoplasmic domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Receptors for interleukin (IL)-10 and IL-6-type cytokines use similar signaling mechanisms for inducing transcription through IL-6 response elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Interleukin-10 suppression of myeloid cell activation--a continuing puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Signal transducer and activator of transcription 3 (STAT3) and Suppressor of Cytokine Signaling (SOCS3) balance controls cytotoxicity and IL-10 expression in decidual-like natural killer cell line NK-92.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

NDRG2-mediated Modulation of SOCS3 and STAT3 Activity Inhibits IL-10 Production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Interleukin-10 and the regulation of mitogen-activated protein kinases: are these signalling modules targets for the anti-inflammatory action of this cytokine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Expression of interleukin 10 in human melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Stimulation of angiogenesis resulting from cooperation between macrophages and MDA-MB-231 breast cancer cells: proposed molecular mechanism and effect of tetrathiomolybdate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

High incidence of interleukin 10 mRNA but not interleukin 2 mRNA detected in human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Macrophage deactivation by interleukin 10

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

IL-10 inhibits granulocyte-macrophage colony-stimulating factor-dependent human monocyte survival at the early stage of the culture and inhibits the generation of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Paradoxical effects of interleukin‐10 on the maturation of murine myeloid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Induction of interleukin-10 in the T helper type 17 effector population by the G protein coupled estrogen receptor (GPER) agonist G-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Effects of thalidomide on long-term bone marrow cultures from patients with myelodysplastic syndromes: induction of IL-10 expression in the stromal layers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

c-Maf regulates IL-10 expression during Th17 polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Inhibition of interleukin-10 by the immunomodulator AS101 reduces mesangial cell proliferation in experimental mesangioproliferative glomerulonephritis: association with dephosphorylation of STAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Interleukin-10 and the immune response against cancer: a counterpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Dendritic cell dysfunction in cancer: a mechanism for immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

IL-10 inhibits apoptotic cell death in human T cells starved of IL-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Effects of platelet-derived growth factor and interleukin-10 on Fas/Fas-ligand and Bcl-2/Bax mRNA expression in rat hepatic stellate cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

IL-10 promotes resistance to apoptosis and metastatic potential in lung tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Interleukin-10 promotes B16-melanoma growth by inhibition of macrophage functions and induction of tumour and vascular cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Interleukin-10 promotes the maintenance of antitumor CD8(+) T-cell effector function in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Cutting Edge: IL-10-producing CD4+ T cells mediate tumor rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

MHC class I antigens, immune surveillance, and tumor immune escape.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Interleukin-10 enhances the therapeutic effectiveness of a recombinant poxvirus-based vaccine in an experimental murine tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Interleukin-10 gene transfer inhibits murine mammary tumors and elevates nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Significance of interleukin-6 (IL-6) in breast cancer (review).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Oestrogen receptor negative breast cancers exhibit high cytokine content

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Cytokine comparisons between women with breast cancer and women with a negative breast biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Chemotherapy targeted to cancer tissue potentiates antigen-specific immune response induced by vaccine for in vivo antigen loading and activation of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Paclitaxel causes mouse splenic lymphocytes to a state hyporesponsive to lipopolysaccharide stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Relationship between IL-10 and tumor markers in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Hypomethylation of the interleukin-10 gene in breast cancer tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-β1 and upregulate expression of regulatory molecules on T cells: do they protect breast cancer cells from the immune response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Human breast tumor cells express IL-10 and IL-12p40 transcripts and proteins, but do not produce IL-12p70

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Activated lymphocytes from breast cancer patients express the characteristics of type 2 helper cells--a possible role for breast cancer-associated p43.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Association of interleukin-10 gene polymorphisms with breast cancer in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Association of interleukin-10 gene variation with breast cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

An investigation of polymorphism in the interleukin-10 gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X

Computational analysis of simulated SNP interactions between 26 growth factor-related genes in a breast cancer association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1855-X